Evidence-based guideline for dust mite allergen immunotherapy in children with allergic asthma (Medical Version)
10.3760/cma.j.cn101070-20240223-00106
- VernacularTitle:儿童过敏性哮喘尘螨过敏原特异性免疫治疗循证指南(医生版)
- Keywords:
Child;
Allergic asthma;
Dust mite;
Allergen immunotherapy
- From:
Chinese Journal of Applied Clinical Pediatrics
2024;39(6):401-417
- CountryChina
- Language:Chinese
-
Abstract:
The prevalence of allergic asthma(AA) in children is increasing trend.Dust mite is the most common inhaled allergen.Dust mite allergen immunotherapy(AIT) is the cause treatment of allergic diseases.Currently, there are many problems of dust mite AIT in children with AA among clinical physicians in China.Therefore, based on evidence-based medicine at home and abroad, combined with the experience of experts, this guideline was formulated, which includes indications, treatment timing, treatment approaches, clinical efficacy evaluation, prevention and management of adverse reactions and drug combination of dust mite AIT.This guideline aims to further standardize the application of dust mite AIT in children with AA and improve the diagnosis, treatment and management level of AA in children.
